Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$0.57 0.00 (0.00%)
(As of 11/20/2024 ET)

QTI vs. CLGN, MLSS, BLAC, COCH, ICAD, OM, XAIR, POCI, CODX, and BSGM

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include CollPlant Biotechnologies (CLGN), Milestone Scientific (MLSS), Bellevue Life Sciences Acquisition (BLAC), Envoy Medical (COCH), iCAD (ICAD), Outset Medical (OM), Beyond Air (XAIR), Precision Optics (POCI), Co-Diagnostics (CODX), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry.

QT Imaging vs.

QT Imaging (NASDAQ:QTI) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment.

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 75.4% of QT Imaging shares are held by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

QT Imaging has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500.

QT Imaging has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -2,535.70%. QT Imaging's return on equity of 0.00% beat CollPlant Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
CollPlant Biotechnologies -2,535.70%-65.98%-54.37%

CollPlant Biotechnologies has a consensus price target of $11.00, indicating a potential upside of 160.05%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts plainly believe CollPlant Biotechnologies is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CollPlant Biotechnologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

CollPlant Biotechnologies received 136 more outperform votes than QT Imaging when rated by MarketBeat users.

CompanyUnderperformOutperform
QT ImagingN/AN/A
CollPlant BiotechnologiesOutperform Votes
136
59.13%
Underperform Votes
94
40.87%

In the previous week, QT Imaging had 5 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 5 mentions for QT Imaging and 0 mentions for CollPlant Biotechnologies. QT Imaging's average media sentiment score of 1.56 beat CollPlant Biotechnologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the media.

Company Overall Sentiment
QT Imaging Very Positive
CollPlant Biotechnologies Neutral

QT Imaging has higher earnings, but lower revenue than CollPlant Biotechnologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT ImagingN/AN/A-$4.03MN/AN/A
CollPlant Biotechnologies$10.96M4.42-$7.02M-$1.54-2.75

Summary

CollPlant Biotechnologies beats QT Imaging on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$12.44M$3.37B$5.01B$8.81B
Dividend YieldN/A1.65%5.16%4.06%
P/E RatioN/A19.01134.3717.77
Price / SalesN/A88.031,158.6875.18
Price / CashN/A46.1733.5332.53
Price / Book-0.303.734.674.68
Net Income-$4.03M$92.21M$119.07M$226.08M
7 Day Performance16.52%-3.40%-1.83%-1.04%
1 Month Performance-14.96%6.80%-3.62%1.04%
1 Year PerformanceN/A17.06%31.63%26.28%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$0.57
flat
N/AN/A$12.44MN/A0.00N/APositive News
Gap Up
CLGN
CollPlant Biotechnologies
1.8582 of 5 stars
$4.23
+1.0%
$11.00
+160.0%
-24.2%$48.43M$10.96M-2.7570Upcoming Earnings
MLSS
Milestone Scientific
2.1701 of 5 stars
$0.68
+9.7%
$1.25
+84.4%
-15.8%$48.30M$9.83M0.0030Analyst Forecast
BLAC
Bellevue Life Sciences Acquisition
N/A$11.60
-0.6%
N/A+11.0%$46.86MN/A0.00N/A
COCH
Envoy Medical
3.0553 of 5 stars
$2.15
+5.4%
$7.92
+268.2%
+115.0%$42.14M$320,000.000.0034Gap Up
ICAD
iCAD
0.526 of 5 stars
$1.55
-1.3%
N/A+16.2%$41.40M$18.94M-11.8867Analyst Upgrade
High Trading Volume
OM
Outset Medical
2.5666 of 5 stars
$0.73
-2.7%
$4.70
+547.7%
-86.5%$39.44M$130.38M0.00520
XAIR
Beyond Air
4.5392 of 5 stars
$0.49
-5.8%
$3.67
+645.9%
-69.1%$35.49M$1.16M-0.3570Gap Down
POCI
Precision Optics
0.8663 of 5 stars
$5.35
+0.6%
N/A-11.1%$33.78M$19.10M0.0080
CODX
Co-Diagnostics
4.3602 of 5 stars
$1.04
-2.8%
$1.50
+44.2%
-27.8%$33.21M$6.81M-0.75100Short Interest ↓
Gap Down
BSGM
BioSig Technologies
N/A$1.87
-4.1%
N/A-45.1%$32.03M$20,000.000.0050

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners